The concepts of remission and recovery in schizophrenia
- PMID: 16944406
- DOI: 10.1055/s-2006-949513
The concepts of remission and recovery in schizophrenia
Abstract
Objective: To examine the past and current research into the concepts of remission and recovery in schizophrenia.
Data sources: An electronic literature search of studies published between January 1990-April 2005 examining the concepts of remission and recovery in schizophrenia and the treatment of schizophrenia with antipsychotic agents was performed using Medline and EMBASE. Primary research parameters were 'schizophrenia', 'remission', 'recovery', 'meta-analysis', 'antipsychotics', 'atypicals', 'conventional', 'cognition', 'function' and 'quality of life'.
Study selection: English language articles, original research articles, reviews and other articles of interest were reviewed.
Data extraction: Data quality was determined by publication in the peer-reviewed literature and the most important information was identified.
Data synthesis: A number of different definitions of remission and recovery have been previously used, which has made comparison of study results problematic. Recently, the first operational definition of remission, based on Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria (DSM-IV) for schizophrenia, was developed. It is hoped that this will provide a standard tool for assessing the effectiveness of treatments for schizophrenia. Recovery, which encompasses both symptom remission and more functional aspects of patient's well being, such as cognition, social functionality and quality of life, is still to be satisfactorily defined. Although recent studies on new generation antipsychotics have examined some proxy outcomes related to recovery, further research is required.
Conclusions: Until the definition for 'recovery' is further elucidated, factors such as symptom control and remission, and functional aspects of recovery such as improvements in cognition and social functioning, which are quantifiable, should be used as measures of treatment outcome and markers of recovery.
Similar articles
-
Improving patient outcomes in schizophrenia: achieving remission.J Psychopharmacol. 2006 Nov;20(6 Suppl):57-61. doi: 10.1177/1359786806071248. J Psychopharmacol. 2006. PMID: 17046987 Review.
-
The concepts of remission and recovery in schizophrenia.Curr Opin Psychiatry. 2011 Mar;24(2):114-21. doi: 10.1097/YCO.0b013e3283436ea3. Curr Opin Psychiatry. 2011. PMID: 21285703 Review.
-
Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?Ann Clin Psychiatry. 2007 Apr-Jun;19(2):133-43. doi: 10.1080/10401230701334606. Ann Clin Psychiatry. 2007. PMID: 17612853 Review.
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
Symptom domains of schizophrenia: the role of atypical antipsychotic agents.J Psychopharmacol. 2006 Nov;20(6 Suppl):6-19. doi: 10.1177/1359786806071237. J Psychopharmacol. 2006. PMID: 17046984 Review.
Cited by
-
Structured Evaluation of Rehabilitation Programs Outcomes in Psychiatry: Application of a Recovery-Centered Model.Psychiatr Q. 2021 Dec;92(4):1513-1530. doi: 10.1007/s11126-021-09884-0. Epub 2021 May 25. Psychiatr Q. 2021. PMID: 34032953 Free PMC article.
-
Psychological Resilience to Suicidal Experiences in People with Non-Affective Psychosis: A Position Paper.Int J Environ Res Public Health. 2022 Mar 23;19(7):3813. doi: 10.3390/ijerph19073813. Int J Environ Res Public Health. 2022. PMID: 35409502 Free PMC article. Review.
-
Symptomatic Remission Along the Clinical Psychosis Spectrum: A Historical and Conceptual Review.Noro Psikiyatr Ars. 2021 Sep 20;58(Suppl 1):S3-S6. doi: 10.29399/npa.27701. eCollection 2021. Noro Psikiyatr Ars. 2021. PMID: 34658628 Free PMC article. Review.
-
Prediction of antipsychotics efficacy based on a polygenic risk score: a real-world cohort study.Front Pharmacol. 2024 Mar 8;15:1274442. doi: 10.3389/fphar.2024.1274442. eCollection 2024. Front Pharmacol. 2024. PMID: 38523642 Free PMC article.
-
Gender impact on the outcome of rehabilitation programs in psychiatry: Brief report from a metropolitan residential rehabilitative service.Front Psychiatry. 2023 Mar 30;14:1145940. doi: 10.3389/fpsyt.2023.1145940. eCollection 2023. Front Psychiatry. 2023. PMID: 37113552 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous